The American rapper Lil Nas X has announced a bipolar diagnosis after a stint in rehab, prompting British mental health charities to renew calls for decriminalisation. As a financial editor, I view this through the lens of balance sheets. The NHS spends an estimated £1.
4bn annually on mental health services, much of it on crisis intervention. Drugs policy, meanwhile, costs billions in enforcement and incarceration. Charities argue that decriminalisation would shift resources from prisons to treatment, yielding better returns.
But we must be wary of moral hazard. Markets abhor uncertainty, and decriminalisation could trigger capital flight if perceived as laxity. Yet the current system also carries costs: lost productivity from untreated illness, stigma that deters investment in human capital.
The rapper’s case highlights a broader portfolio risk. We need a risk assessment, not a leap of faith. Gilt yields are stable for now, but watch the inflation of social costs if we do nothing.
